CTSD and cancer: Although Res has been shown capable to induce cancer cell death through lysosomal cathepsin D [54] and L [55] release, in our experiments the inhibition of lysosomal cathepsins by pharmaceutical protease inhibitors did not delay the death process (Figure 6E).